Department of Health and Social Care (DHSC) has issued a medicine supply notification for Medroxyprogesterone (Provera®) 10mg tablets.
MSN/2022/074
Tier 3 – high impact
Date of issue 1st September 2022
Medroxyprogesterone (Provera®) 10mg tablets are in limited supply until mid-September 2022.
Lower strength medroxyprogesterone tablets (2.5mg and 5mg) remain available but will not be able to support an increase in demand.
Norethisterone 5mg tablets remain available and will be able to support an increase in demand.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
The post Medicine Supply Notification: Medroxyprogesterone (Provera® ) 10mg tablets appeared first on PSNC Website.